Indivior to end Reckitt copacker supply deal by Jan 15, 2027
Indivior entered a Deed of Variation and Termination with Reckitt Benckiser Healthcare to accelerate the end of their Copacker Supply Agreement for SUBOXONE and SUBUTEX tablets to January 15, 2027, with RB continuing manufacturing additional units until then.
Indivior entered into a Deed of Variation and Termination with Reckitt Benckiser Healthcare to bring forward the end of their Copacker Supply Agreement for SUBOXONE and SUBUTEX tablets to January 15, 2027. The agreement will stay in effect until that date, and RB will manufacture additional units before then.